谷胱甘肽
化学
烟酰胺腺嘌呤二核苷酸磷酸
生物化学
GPX4
伊布塞伦
抗氧化剂
氧化还原
过氧化脂质
脂质过氧化
细胞毒性
烟酰胺腺嘌呤二核苷酸
谷胱甘肽二硫化物
氧化应激
细胞生长
谷胱甘肽过氧化物酶
GPX1型
活性氧
细胞生物学
生物物理学
过氧化物
癌细胞
细胞
香菇多糖
平衡
氧化磷酸化
作者
Shulin Du,Moyi Zhang,Hao Zheng,Ran Gao,Jinrong Chen,Rouyu Lin,Jing Li,Mengsi Zhang,Hao Zhang
出处
期刊:Theranostics
[Ivyspring International Publisher]
日期:2026-09-09
卷期号:16 (16): 9185-9199
摘要
The adaptive regulation of abnormal redox homeostasis endows tumor cells with robust survival capabilities, with glutathione (GSH) serving as one of the antioxidant cornerstones, which significantly impairs the efficacy of many regulated cell death-related therapies, including disulfidptosis and ferroptosis.Methods: Herein, Au nanodot-loaded iron-dithiodiglycolic acid (SS) nanoparticles (FeSS@Au NPs) were engineered to potentiate disulfidptosis and ferroptosis via triple GSH depletion for oncotherapy.FeSS NPs were pre-prepared by dominant coordination-driven self-assembly between FeCl3 and SS.FeSS@Au NPs were prepared through the in situ growth of Au nanodots on FeSS NPs.FeSS@Au NPs were systematically evaluated, including the structure, characteristics, stability and antitumor activity.Results: Fe 3+ in FeSS@Au NPs can oxidize GSH into glutathione (GSSG) through redox reaction.SS can deplete GSH through thiol-disulfide exchange.Au nanodots can disrupt cystine-to-cysteine transformation by attenuating nicotinamide adenine dinucleotide phosphate supplement with its glucose oxidase-like activity, thus downregulating GSH synthesis by providing less cysteine.Resulting from GSH depletion, the accumulated disulfides, including GSSG and cystine, can trigger disulfidptosis.Meanwhile, the inhibited glutathione peroxidase 4 activity and elevated •OH via Fenton reaction can promote lipid peroxide accumulation, thereby boosting ferroptosis.Conclusions: Through a triple GSH depletion strategy, FeSS@Au NPs achieve robust tumor growth inhibition by inducing disulfidptosis and ferroptosis, providing a promising therapeutic approach for efficient tumor treatments.
科研通智能强力驱动
Strongly Powered by AbleSci AI